Literature DB >> 21470205

Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.

Martin A Sticht1, Jonathan Z Long, Erin M Rock, Cheryl L Limebeer, Raphael Mechoulam, Benjamin F Cravatt, Linda A Parker.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the role of 2-arachidonoyl glycerol (2AG) in the regulation of nausea and vomiting using animal models of vomiting and of nausea-like behaviour (conditioned gaping). EXPERIMENTAL APPROACH: Vomiting was assessed in shrews (Suncus murinus), pretreated with JZL184, a selective monoacylglycerol lipase (MAGL) inhibitor which elevates endogenous 2AG levels, 1 h before administering the emetogenic compound, LiCl. Regulation of nausea-like behaviour in rats by exogenous 2AG or its metabolite arachidonic acid (AA) was assessed, using the conditioned gaping model. The role of cannabinoid CB(1) receptors, CB(2) receptors and cyclooxygenase (COX) inhibition in suppression of vomiting or nausea-like behaviour was assessed. KEY
RESULTS: JZL184 dose-dependently suppressed vomiting in shrews, an effect prevented by pretreatment with the CB(1) receptor inverse agonist/antagonist, AM251. In shrew brain tissue, JZL184 inhibited MAGL activity in vivo. In rats, 2AG suppressed LiCl-induced conditioned gaping but this effect was not prevented by AM251 or the CB(2) receptor antagonist, AM630. Instead, the COX inhibitor, indomethacin, prevented suppression of conditioned gaping by 2AG or AA. However, when rats were pretreated with a high dose of JZL184 (40 mg·kg(-1) ), suppression of gaping by 2AG was partially reversed by AM251. Suppression of conditioned gaping was not due to interference with learning because the same dose of 2AG did not modify the strength of conditioned freezing to a shock-paired tone. CONCLUSIONS AND IMPLICATIONS: Our results suggest that manipulations that elevate 2AG may have anti-emetic or anti-nausea potential. LINKED ARTICLES: This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue-7.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21470205      PMCID: PMC3423233          DOI: 10.1111/j.1476-5381.2011.01407.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes.

Authors:  M P Patricelli; D K Giang; L M Stamp; J J Burbaum
Journal:  Proteomics       Date:  2001-09       Impact factor: 3.984

Review 2.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

3.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo.

Authors:  K R Kozak; B C Crews; J L Ray; H H Tai; J D Morrow; L J Marnett
Journal:  J Biol Chem       Date:  2001-07-10       Impact factor: 5.157

5.  The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.

Authors:  Nissar A Darmani
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

6.  Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea.

Authors:  C L Limebeer; L A Parker
Journal:  Neuroreport       Date:  1999-12-16       Impact factor: 1.837

7.  Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret.

Authors:  M D Van Sickle; L D Oland; W Ho; C J Hillard; K Mackie; J S Davison; K A Sharkey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

8.  Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).

Authors:  Linda A Parker; Magdalena Kwiatkowska; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

9.  Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.

Authors:  Linda A Parker; Raphael Mechoulam; Coralynn Schlievert; Laura Abbott; Melissa L Fudge; Page Burton
Journal:  Psychopharmacology (Berl)       Date:  2003-01-15       Impact factor: 4.530

Review 10.  A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation.

Authors:  Thien P Dinh; Támas F Freund; Daniele Piomelli
Journal:  Chem Phys Lipids       Date:  2002-12-31       Impact factor: 3.329

View more
  26 in total

Review 1.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 2.  Therapeutic potential of monoacylglycerol lipase inhibitors.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Life Sci       Date:  2012-11-08       Impact factor: 5.037

3.  Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.

Authors:  Joel E Schlosburg; Steven G Kinsey; Bogna Ignatowska-Jankowska; Divya Ramesh; Rehab A Abdullah; Qing Tao; Lamont Booker; Jonathan Z Long; Dana E Selley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2014-05-21       Impact factor: 4.030

Review 4.  Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.

Authors:  Rebecca A Kohnz; Daniel K Nomura
Journal:  Chem Soc Rev       Date:  2014-03-28       Impact factor: 54.564

5.  Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

6.  Delineation of vagal emetic pathways: intragastric copper sulfate-induced emesis and viral tract tracing in musk shrews.

Authors:  Charles C Horn; Kelly Meyers; Audrey Lim; Matthew Dye; Diana Pak; Linda Rinaman; Bill J Yates
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

7.  Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.

Authors:  Cheryl L Limebeer; Rehab A Abdullah; Erin M Rock; Elizabeth Imhof; Kai Wang; Aron H Lichtman; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2013-09-17       Impact factor: 4.530

8.  The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Authors:  D M Kerr; B Harhen; B N Okine; L J Egan; D P Finn; M Roche
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus.

Authors:  Linda A Parker; Micah J Niphakis; Rachel Downey; Cheryl L Limebeer; Erin M Rock; Martin A Sticht; Heather Morris; Rehab A Abdullah; Aron H Lichtman; Benjamin F Cravatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-03       Impact factor: 4.530

Review 10.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.